Registry for treating vertebrobasilar dissecting aneurysms in China
Registry of Endovascular Treatment for Vertebrobasilar Dissecting Aneurysms in China
This study is collecting information from patients with unruptured vertebrobasilar dissecting aneurysms to see how these conditions progress and how best to treat them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Beijing Tiantan Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT06541106 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect data on patients with unruptured vertebrobasilar dissecting aneurysms (VBDAs) to better understand their prognosis and treatment outcomes. It involves a multi-disciplinary assessment approach to evaluate the condition and potential interventions for these patients. The study will track the incidence and progression of VBDAs, which are significant causes of stroke in young and middle-aged individuals, using advanced medical imaging technologies. By gathering comprehensive clinical data, the study seeks to improve the management and treatment strategies for this complex condition.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18-80 diagnosed with unruptured vertebrobasilar dissecting aneurysms.
Not a fit: Patients who have undergone microsurgery or have serious comorbid conditions that affect follow-up may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding and treatment of vertebrobasilar dissecting aneurysms, potentially reducing the risk of stroke and improving patient outcomes.
How similar studies have performed: While there have been studies on dissecting aneurysms, this specific registry approach focusing on VBDAs is relatively novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 18-80 years old; 2. Patients diagnosis of "unruptured vertebrobasilar dissecting aneurysm". Exclusion Criteria: 1. Patients did not undergo a cranial MRI; 2. Missing critical clinical baseline; 3. Missing pre-treatment imaging; 4. Receiving microsurgery; 5. The combination of other serious diseases during diagnosis will significantly affect the follow-up of patients; 6. CT/MRI shows intracranial hemorrhage or subarachnoid hemorrhage (SWI microbleeds are ignored).
Where this trial is running
Beijing, Beijing Municipality
- Beijing Tiantan Hospital — Beijing, Beijing Municipality, China (Recruiting)
Study contacts
- Study coordinator: Linggen Dong, MD
- Email: donglinggen@163.com
- Phone: +8613701376177
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.